(Q33349096)

26 July 2017

title

High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma (English)

1 reference

malignant pheochromocytoma

26 July 2017

1 reference

1 reference

2

Katherine K Matthay

1 reference

26 July 2017

4

John Huberty

1 reference

26 July 2017

Brian Rose

1

1 reference

26 July 2017

David Price

3

1 reference

26 July 2017

Barbara Klencke

5

1 reference

26 July 2017

Jeffrey A Norton

6

1 reference

26 July 2017

Paul A Fitzgerald

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

26 July 2017

1 reference

26 July 2017

volume

98

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

239-248

1 reference

Pheochromocytoma in Italy: a multicentric retrospective study

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Malignant pheochromocytoma: clinical course and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Scintigraphic Localization of Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Sympathetic Nervous System Blocking Agents. III. Derivatives of Benzylguanidine1-3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Current Management of Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

A 15-year experience with chemotherapy of patients with paraganglioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma). A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Palliative chemotherapy for malignant pheochromocytoma: symptomatic palliation of two cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Acute myeloid leukemia after iodine-131 treatment for thyroid disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

No-carrier-added synthesis of meta-[131I]iodobenzylguanidine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11518

7 January 2021

Identifiers

DOI

10.1002/CNCR.11518

1 reference

26 July 2017

1 reference